Impact of TAILORx on Chemotherapy Prescribing and 21-Gene Recurrence Score–Guided Treatment Costs in Patients With Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of TAILORx on chemotherapy prescribing and 21-gene recurrence score-guided treatment costs in a population-based cohort of patients with breast cancer
Cancer 2022 Feb 15;128(4)665-674, ME Tesch, C Speers, RM Diocee, L Gondara, SJ Peacock, A Nichol, CA LohrischFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.